INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 444m ago
HOUSE PTR44m ago
SEC 13F44m ago
ROBINHOOD CHAIN44m ago
Public company

ZURAZura Bio Ltd

CIK 0001855644

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score19
Connections6with evidence

ZURA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
NA
Nirula AjayDirector
ZURAZura Bio Ltd
Grant or award
A—
51.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Schoch Steven JDirector · Jun 22, 2026
  • ← Insider ofevidence
    Eisner MarkDirector · Jun 22, 2026
  • ← Insider ofevidence
    Nirula AjayDirector · Mar 5, 2026
15
TP
Thiara ParvinderDirector
ZURAZura Bio Ltd
Grant or award
A
—
51.0K sh
Jun 17, 2026
Jun 22, 2026
traded Jun 17, 2026
+5d
SEC FORM 4

Evidence

15
SJ
Schoch Steven JDirector
ZURAZura Bio Ltd
Grant or award
A—
51.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

15
EM
Eisner MarkDirector
ZURAZura Bio Ltd
Grant or award
A—
51.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

19
NA
Nirula AjayDirector
ZURAZura Bio Ltd
Grant or award
A—
37.8K sh
Feb 21, 2026Mar 5, 2026
traded Feb 21, 2026
+12dSEC FORM 4

Evidence

9
TP
Thiara ParvinderDirector
ZURAZura Bio Ltd
Grant or award
A—
38.8K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence

9
KC
Kulkarni Sandeep ChidambarDirector, Chief Executive Officer
ZURAZura Bio Ltd
Grant or award
A—
2.93M sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

← Insider ofevidence
Thiara Parvinder
Director · Jan 27, 2026
  • ← Insider ofevidence
    Kulkarni Sandeep ChidambarDirector, Chief Executive Officer · Jan 23, 2026